Loading company…
OmniaMed researches and develops medicines for Parkinson's disease using nitrogen monoxide.
Founded in 2019 and based in Pohang, South Korea, OmniaMed researches and develops drugs for Parkinson's disease using nitrogen monoxide.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in